Format
Sort by

Send to:

Choose Destination

Search results

Items: 4

1.

Recommendations on the use of biosimilars by the Brazilian Society of Rheumatology, Brazilian Society of Dermatology, Brazilian Federation of Gastroenterology and Brazilian Study Group on Inflammatory Bowel Disease--Focus on clinical evaluation of monoclonal antibodies and fusion proteins used in the treatment of autoimmune diseases.

Azevedo VF, Meirelles Ede S, Kochen Jde A, Medeiros AC, Miszputen SJ, Teixeira FV, Damião AO, Kotze PG, Romiti R, Arnone M, Magalhães RF, Maia CP, de Carvalho AV.

Autoimmun Rev. 2015 Sep;14(9):769-73. doi: 10.1016/j.autrev.2015.04.014. Epub 2015 May 1. Review.

PMID:
25936608
2.

Pharmacokinetics of monoclonal antibodies used for inflammatory bowel diseases in pregnant women.

Stone RH, Hong J, Jeong H.

J Clin Toxicol. 2014 Aug;4(4). pii: 209. Epub 2014 Aug 25.

3.

[Practical use of anti-TNF monoclonal antibodies in inflammatory bowel diseases].

Allez M.

Gastroenterol Clin Biol. 2008 May;32(5 Pt 1):467-77. doi: 10.1016/j.gcb.2008.03.002. Epub 2008 May 2. French. No abstract available.

4.

Inflammatory bowel diseases and thymus disorder: reactivity of thymocytes with monoclonal antibodies.

Mizuno Y, Muraoka M, Shimabukuro K, Toda K, Miyagawa K, Yoshimatsu H, Tsuchiya M.

Bull Tokyo Dent Coll. 1990 May;31(2):137-41.

PMID:
2131166
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk